A new study funded by the Ewing Marion Kauffman Foundation and conducted by researchers at Duke University and Harvard Law School finds that Indian and Chinese drug companies are fast developing their research capabilities, but still must partner with multinational drug makers to develop proprietary products. Among 2006 pharmaceutical patent applications, 5.5% contained at least […]
According to Ernst and Young’s “2008 Global Biotechnology Report,” global revenues from biotech companies increased 8% in 2007 to $84.8 billion. Global R&D expenditure increased 7% to $31.8 billion. Excluding the acquisition of Medimmune by AstraZeneca and Merck KGaA’s buyout of Serono, global revenue and R&D would have increased 17% and 26%, respectively. In the […]
Capital expenditure budgets (CapEx) for 22 public food companies surveyed by Food Processing are expected to increase 7.1% to $11.067 billion in 2008. Fifteen of the surveyed companies plan to increase their CapEx, with five increasing spending more than 25%. Pilgrim’s Pride and Hershey reported the largest planned increases, with CapEx growth of 72% and […]
Chinese pharmaceuticals could drive down the price of generic drugs. According to IMS Health, the US Department of Agriculture’s (USDA) approval last year of Zhejiang Huahi Pharmaceutical’s generic form of Nevirapine, an AIDS drug, indicates a trend. IMS reports that at least 10 other Chinese companies are bringing generics to market, with some appearing as […]
The new Food, Conservation and Energy Act of 2008 will reorganize the US Department of Agriculture’s (USDA) $2 billion worth of research programs. The extramural Cooperative State Research, Education and Extension Service will be renamed the National Institute for Food and Agriculture (NIFA). For making competitive grants, NIFA will replace the National Research Initiative (NRI) […]
Agriculture: Across the globe, governments and biotech companies are attempting to reconcile food shortages and increasing food prices with strict regulations on genetically modified (GM) crops. In a recent move, food manufacturers in Japan and Korea have abandoned their adherence to unmodified corn, which has increased three times in price from 2006, for its GM […]
Metals: In 2007, mergers and acquisitions (M&A) activity in the metals industry increased 67% to $144.7 billion. Aluminum deals represented 56 of the year’s 411 disclosed transactions and amounted to $77.3 billion, almost four times the $21.3 billion spent on aluminum deals between 2003 and 2006. This increase was primarily due to Rio Tinto’s $38.1 […]
According to the “2008 Pharmaceutical Industry Profile” released by the Pharmaceutical Research and Manufacturers of America (PhRMA), R&D spending by PhRMA-member companies rose 2.5% to $44.530 billion in 2007. Member companies’ 2007 sales increased 6.6% to $271.515 billion. As a result, R&D as a percentage of sales was 16.4%, down from 17.1% in 2006. In […]
The credit crisis could affect the ability of biotech companies worldwide to raise new funding. Although venture capital funding for biotech did not slow last year, some observers believe the criteria for such investments will become stricter and competition between late- and early-stage companies for such funding could increase. Last year, funding for biotech and […]
Global food sales grew an average of 1.8% last year, hampered by price increases for most staple items, including milk, eggs, corn and wheat. Food producers have also been impacted by higher electricity and fuel costs, part of what one analyst described as a “perfect storm” for the industry. In 2007, Kraft spent $1.3 billion […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
